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Abstract: Background: Zinc defi-
ciency is common in the Paediatric 
age group but the extent of this 
disorder is unknown in HIV in-
fected children in Nigeria prompt-
ing this study.  
Objective: To determine the preva-
lence of zinc deficiency in HIV 
seropositive children, and compare 
this with age and sex matched con-
trols. 
Methods: A case control study of 
70 HIV sero-positive and age and 
sex matched HIV sero-negative 
children was carried out in the Uni-
versity of Port Harcourt Teaching 
Hospital between 1st of June, 2009 
and 31st of May, 2010.  We col-
lected demographic, clinical, hae-
matological and biochemical pa-
rameters from cases and controls, 
and analysed these using SPSS 20.  
Results: Sixty percent of the sub-
jects were zinc deficient as against 
41.4% of the controls, p= 0.028. 
Subjects that were zinc deficient 
were more likely to be in higher 
HIV disease stages, p = 0.003, in 
lower socio-economic classes and 
aged less than 60 months. We con-
clude that there is a high preva-
lence of zinc deficiency in HIV 
sero-positive children and they 
should have zinc supplementation 
immediately they are diagnosed to 
reduce their morbidity and  
mortality. 
 





Zinc is an essential micronutrient found in every cell of 
every living organism and is necessary for cell growth, 
wound healing, mucosal epithelisation, DNA synthesis, 
and support of a healthy immune system.1 Zinc is found 
in high concentration in flesh of beef, pork, poultry, fish 
and shellfish, and with lesser amounts in eggs and dairy 
products. Phytates in plants form complexes with zinc 
preventing absorption from the jejunum. Consumption 
of gruels made from maize, sorghum, or millet-
containing phytates reduce absorption and cause defi-
ciency of zinc. Rapid turnover of cells and consequent 
rebuilding during acute and chronic illnesses cause re-
duction in micronutrients including zinc.2,3   Caulfield et 
al2 in their analysis stated that children in developed 
countries have normal  serum zinc levels, but most chil-
dren in developing countries are deficient because they
consume diets low in zinc.2 The estimated global preva-
lence of zinc deficiency as at 2004 was 31%, 3 but this is 
lower in Nigerian children where 20% are said to be 
deficient in zinc. 4 
 
Zinc deficiency manifests clinically with increased se-
verity and duration of diarrhoea and pneumonia, poor 
wound healing, dermatitis, and in severe forms, dwarf-
ism. It is for this reason the World Health Organistion 
(W.H.O) recommended zinc supplementation in children 
with diarrhoea and pneumonia.5 This is known to reduce 
the severity, frequency and duration of diarrhoea and
pneumonia in children and also those infected with Hu-
man immunodeficiency virus. The prevalence of HIV 
infection has gradually dropped and this is especially so 
in Nigeria where it is now 3.4% from a high of 5.4% 
over a period of 6 years6. However, HIV has been asso-
ciated with over 2.1 million deaths and 330,000 of these 
are children as at the end of 2007. Nte et al actually 
showed a 2.1% HIV associated deaths in University of 
Port Harcourt Teaching Hospital Nigeria.7 HIV is associ-
ated with under-nutrition as demonstrated by studies in 
Africa and Nigeria, and most of these were macronutri-
ent deficiencies.6,8 Steenkamp et al8 in South Africa re-
ported zinc deficiency in some children with HIV and 
noticed that nutritional rehabilitation (with calorie and 
protein) alone did not improve serum zinc levels. For 
this reason, zinc supplementation programmes were 
initiated and sustained in East and South African chil-
dren with HIV infection. The prevalence of zinc defi-
ciency in HIV infected children is unknown in Nigeria, 
and it is for this reason we decided to carry out this 
study and make recommendations based on the results 
of the investigation.  
Objectives 
 
To determine the prevalence of zinc deficiency in HIV 
sero positive children and age and sex matched controls 
(HIV sero-negative children) attending the University of 
Port Harcourt Teaching Hospital. 




Materials and Methods 
 
This case-control study was carried out in the Paediat-
rics department of the University of Port Harcourt 
Teaching Hospital between 1st of June, 2009 and 31st of 
May, 2010, over a one year period. Ethical approval was 
obtained from the UPTH research and ethics committee 
prior to the commencement of the study. Included in the 
study, were newly diagnosed and HAART naive HIV 
infected children between ages 18 months and 16 years, 
and age and sex matched HIV negative controls. Sub-
jects were recruited serially as they presented to the de-
partment. When a sero-positive subject who met the 
inclusion criteria was recruited, an age and sex matched 
HIV sero-negative control who met the inclusion criteria 
was recruited as control from the Children Outpatient 
clinics (CHOP), Children Emergency Ward or DTU 
within 72 hours. Excluded from the study were children 
on zinc or multivitamin supplementation. Informed con-
sent was obtained from the parents/guardians of all eligi-
ble children. The minimum sample size (n) of 53 was 
calculated using the prevalence of HIV infection and 
zinc deficiency in children in Nigeria.4 All children had 
detailed clinical history and examination performed be-
fore blood samples were collected for HIV screening 
and serum zinc analyses. Information obtained were 
demography, risk factors for HIV and zinc deficiency, 
and the socioeconomic status of parents/ guardians usi g 




Subjects that were already in care (i.e. receiving other 
management except antiretroviral drugs) for HIV/AIDS 
were not retested for HIV and were recruited after th ir 
parents gave informed consent for the study. Testing of 
new subjects and controls using rapid test kits 
(Determine® and Stat pak was done following the 
guidelines of the Provider Initiated Testing and Counsel-
ling (PITC).10 Needle pricks (from the heel of a foot, or 
the thumb) were used to collect one drop of blood into
the test kit. Initial tests used were Determine HIV 1 and 
2 kits® (Abbot, Japan), and positive samples were re-
tested using the Chembio HIV 1 and 2 Stat- pak kits® 
(Medford, NY, USA).  If there was disparity between 
the two test kit results, a third kit, Gold check® was 
used as “tie-breaker”. Information and post-test counsel-
ling were offered to all patients by the investigator or the 
trained assistants. All samples were tested free by the 
investigator and/ or trained assistants at no cost to the 
study groups. 
 
Serum Zinc Analysis 
 
The serum zinc was analysed at the Obafemi Awolowo 
University Central Science Laboratory, Ile Ife, using 
flame atomic absorption spectrophotometer Model 210, 
manufactured by Buck Scientific Corporation, Connecti-
cut, USA and the laboratory reference range of normal 
was 80 - 120µg/dL. Each sample was done in duplicate 
and the mean recorded. For this study, zinc deficiency 
was defined as serum zinc level less than 80 µg/dL. 
Samples were sent in batches of 20, transported frozen, 
in vaccine rush containers with ice gel packs by courier 
to OAUTH, Ile Ife and received by the Chief scientist or 
his assistants at the CSL, where they were analysed.  
 
Measurements of total WBC, AND CD4+ COUNTS 
 
Blood in the EDTA bottle was used for White Blood 
Cell (WBC) count and differentials as well as the CD 4+ 
cell count. Total WBC count and differentials were d -
termined using Full Automatic Blood cell counter 
(ERMA INCORPORATED® Tokyo). The machine was 
recalibrated daily using standard solution and diluents 
(ERMA INCORPORATED® Control M-6) according to 
manufacturer’s specification.  The white cell count a d 
differential counts were crosschecked with manual dif-
ferential cell counter after every tenth specimen and 
whenever a superfluous result was obtained with 
autoanalyser. Lymphocyte count was calculated using 
total white blood cell count and lymphocyte percentage 
with the formula: 
Lymphocyte count = Lymphocyte percent x total WBC     
   count (mm3)  
                                                  100 
CD4+ cell count was measured in all newly diagnosed 
HIV sero-positive subjects, and controls. The CD4+ cell 
count was measured in the Haematology laboratory of 
UPTH using Partec® Cyflow Counter 05-8401 manu-
factured in Germany. The CD4+% were calculated, after 
getting the total lymphocyte count for each patient using 
the formula: 
 
CD4+%   =     CD4+ cell count x 100 
                         Lymphocyte count   
 
CD4+ count and CD4+ % were used to classify HIV sero





The data collation and analysis were done by the inv sti-
gator, with the help of statisticians. The raw data w s 
collated into a Microsoft Excel sheet in a personal com-
puter. The data was analyzed using SPSS version 20. 
HIV disease was classified using WHO clinical staging 
for infants and children and immune status was classi-
fied using WHO staging classification.10 Serum zinc 
deficiency was defined as serum zinc level less than 
80µg/dL.4 Frequencies were measured using percent-
ages, while arithmetic means were used for continuous 
variables. Test of statistical significance included  
111 
Student‘s t test, Chi square test, Yates correction test 
and Fisher’s exact tests. Test of significance was as-
sessed with 95% confidence interval and p value < 0.05






A total of 268 HIV sero-positive children were seen 
during the study period and of these, 102 (38%) were 
aged eighteen months and above. Ten (10) were ex-
cluded because they had already been started on antiret-
roviral therapy. Fifteen sero-positive patients who were 
eligible were critically ill and died in the CHEW before 
their parents could be counselled for inclusion into the 
study, while seven (7) did not give consent to participate 
in the study. A total number of 140 children (70 HIV 
sero-positive subjects and 70 age and sex matched HIV 
sero-negative controls) were recruited into the study. 
There were 40 (57.1%) males and 30 (42.9%) females in 
each study group, giving a male: female ratio of 1.3:1. 
 
Clinical staging of HIV sero-positive children 
 
Sixty two (88.6%) of the subjects presented in advanced 
to severe stages of diseases (stages 3 and 4). There was 
no child aged 60 months and above in the asymptomatic 
and mild HIV disease stages (Table 1). 
 
Table 1: WHO clinical staging of subjects by age group 
Age related immunological status of HIV sero-positive 
children. 
 
Only 6(8.6%) subjects had normal immunity and 46 
(65.7%) of subjects had advanced to severe immune 
suppression. 
 












          






60-119 0 (0) 0 (0) 14 (20) 6 (8.6) 20 
(28.6) 
120-192 0 (0) 0 (0) 1 (1.5) 2 (2.8) 3 (4.3) 























18-59 2(2.9)  8(11.4) 12(17.1) 25 
(35.7) 
47 (67.1) 
60-119 3 (4.3)  8(11.4) 8 (11.4) 1(1.4) 20 (28.6) 
120-192 1 (1.4)  2 (2.9) 0 (0.0)  0 
(0.0) 
3 (4.3) 
Total 6 (8.6) 18 (25.7) 20(28.6) 26
(37.1) 
70 (100) 
Serum zinc status and study groups  
 
Forty-two (60%) of the subjects and 29 (41.4%) of the
controls were zinc deficient and this difference was sig-
nificant, χ2 = 4.830, p = 0.028. 
 
Serum zinc levels and age groups of subjects and  
controls 
 
For each age group, controls had higher serum zinc lev-
els than the subjects, though this was only significant for 
the 18-59 months age group.  Table 3 shows age-related 
prevalence of zinc deficiency in subjects and controls. 
Of the 47 subjects aged 18-59 months, 28(59.6%) were 
zinc deficient as against 17 (36.1%) in the control g up. 
 
Table 3: Age-related prevalence of zinc deficiency in subjects 
and controls 
Fishers exact test 
 
Serum zinc Levels and HIV disease 
 
The mean serum zinc levels decreased as the WHO HIV 
clinical staging worsened. Subjects in stages 1 and 2 had 
normal mean serum zinc levels while those with ad-
vanced disease, had mean serum zinc levels lower than 
normal (Table 4). There was significant difference in 
mean serum zinc levels between subjects in stages on  
and two (95.319 ±  24.01 ug/dL) and those in stages 
three and four (62.04 ± 28.80 ug/dL), with the latter 
having a lower mean, t = 3.1, p = 0.003.  
 
Table 4: Mean serum zinc levels according to WHO clinical 
staging   
In subjects, the mean serum zinc level in those with nor-
mal immune status was within normal levels, but it was 
low in those who had evidence of immune suppression. 
The mean serum zinc levels were higher in the controls 
than in the subjects across various immune categoris 
except in those with normal immune status. The  
differences were significant in the mild and severe  




          Deficient 
N        n     (%) 
Controls                                           
Deficient 
N       n     (%) 
χ2            p 
 18 – 59 47     28 (59.6) 47     17 (36.1) 5.16    0.02 
60 – 119 20    14  (70.0) 20     11(55.0) 0.96    0.33 
120 – 192 3        0  (0.0) 3        1 (33.3)             0.99* 
Total 70    42  (60) 70    29 (41.4)   
WHO Stage n (%) Mean zinc levels 
ug/dL ±SD 
1 3 (4.3) 113.9  ±34.1 
2 5 (7.1) 84.2    ±2.9 
3 30 (42.9) 73.8    ±23.5 
4 32 (45.7) 51.0    ±30.1 
Total 70 (100) 65.8  ±33.3 
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Table 5: Mean Serum zinc level and immune status of 
subjects and controls 
In the control group, majority 49 (70%) had normal or 
mild immune suppression whereas majority of the  
subjects 46 (66%) had advanced or severe immune  
suppression. One of the controls with advanced immune  
suppression had a very low serum zinc level of 56 µg/dL 
which reduced the mean serum zinc in the group to  
below normal  (Table 6). 
 
Table 6: Immune Status of Zinc Deficient Subjects and  
Controls  
Yates correction test 
 
Serum zinc and Socioeconomic Status of study group 
In subjects, only those in class 1 had normal mean  
serum zinc level, and though there were fluctuations, the 
lower the classes, the lower the mean serum zinc levels. 
The fluctuation was also noted in the control group, but 
mean serum zinc level was normal in classes 1, 2, and 3. 
It was also noticed that the mean serum zinc was lower 
in subjects than controls within the same socio economic 
class, but the differences were not significant as shown 
in Table 7. 
Table 7: Mean serum zinc levels and socioeconomic status of 






Zinc deficiency was seen in 50.7% of the study popula-
tion and this was higher than the 20% previously re-
ported by Maziya-Dixon et al 4 and the estimated global 
Immune 
Status 
        Subjects 
                   Mean zinc 
 n  (%)        µg/dL (±SD) 
        Controls 
                     Mean zinc 
n   (%)         µg/dL (±SD)    t        p 
Normal 6  (8.6)        110.4(±27.6) 22  (31.4)   92.5(±27.4)     1.4   0.168 
Mild 18 (25.7)     69.3 (±23.7) 27  (38.6)   84.8(±25.5)   -2.1   0.046* 
Advanced 20 (28.6)     70.8 (±22.5) 15  (21.4)   79.0(±14.6)   -1.2   0.235 
Severe 26  (37.1)     49.3(±28.1)   6    (8.6)   86.6(±18.7)   -3.9   0.002* 
Total 70  (100)      65.8(±33.3) 70   (100)   86.1(±23.8) 




      Deficient 
N      n(%) 
Controls  
       Deficient 
N     n(%)  
χ2 P 
Normal 6        0(0) 22    8(36.4) 1.53*      0.216 
Mild  18    8(44.4) 27   12(44.4) 0.00 1.00 
Advanced 20     14(70) 15     7(46.7) 1.94 0.163 
Severe  26   20(76.9)   6     2(33.3) 2.52* 0.112 
Total  70     42(60)
  
70    29(41.4)  
Socioeco-
nomic Status 





                   Mean zinc 
n   (%)     µg/dL (±SD)         t       p 
  
1        4 (5.7) 88.6 (±20.2) 3   (4.3)    124.7 (±32.3)   -2.1  0.091   
2       14 (20) 71.4 (±34.3) 18 (25.7)   86.7 (±26.1)    -1.4  0.163   
3     17 (24.3) 79.8 (±24.1) 35  (50)     89.6 (±19.3)    -1.6  0.119   
4     28 (40.0) 58.5 (±26.5) 11  (15.7)  66.7 (±13.4)    -1.0  0.339   
5       7 (10) 37.1 (±31.0)  3   (4.3)     75.5 (±25.8)   -1.8  0.098   
Total  70 (100)        65.8 (±33.3)      70  (100)   86.1(±23.8)   
prevalence of 31%.2 The higher prevalence in this study 
can be accounted for by the fact that the study popula-
tion were ill children as against the study by Maziy -
Dixon et al 4where apparently healthy household chil-
dren (children living in a household i.e. with a family as 
against street children were investigated. Serum zinc 
levels are reduced during acute and chronic infection as 
there is reduced intake, and increased utilization f r 
healing.1 Another reason for the higher prevalence was 
the relatively small sample used in the study compared 
to the larger population by Maziya-Dixon et al.4 In the 
study, only serum zinc level was used to determine z c
deficiency state, whereas the estimated global preva-
lence pooled results from various populations (affluent 
and impoverished) with diverse cultures and feeding 
practices, used degree of stunting in areas where serum 
zinc levels were not available and zinc contents in vari-
ous diets to arrive at their result. The HIV status of the 
children investigated by Hotz et al 3 and Maziya-Dixon 
et al4 was not ascertained and this methodological differ-
ence could have also accounted for the higher preva-
lence in the study. 
 
In the HIV sero-positive children, the prevalence of zinc 
deficiency was 60%. This was higher than the preva-
lence of 54.3% reported by Ndeezi et al11 in Uganda and 
the 20% by Eley et al12 in South Africa. The study inves-
tigated only HAART naïve HIV sero-positive children 
while Ndeezi et al combined children on HAART and 
those that were HAART naïve. Studies have shown that 
HAART improves serum zinc levels probably by reduc-
ing viral load, improving general well being, immune 
status, and invariably, overall nutrition in HIV patients, 
thus reducing the number of HIV sero-positive children 
that will be zinc deficient.13,14 HAART also reduces op-
portunistic infections, and thus reduces the frequency of 
repeated infections and excessive utilization of zinc. The 
higher prevalence of zinc deficiency in HIV sero-
positive children in this study as against that by Eley et 
al, can be explained by the fact that the children investi-
gated by Eley et al were clinically stable, and received 
nutritional rehabilitation, thus improving their macro- 
and micro- nutrient status. In the present study, no at-
tempt was made at nutritional rehabilitation before th y 
were recruited.  
 
The prevalence of zinc deficiency in the control group 
was 41.4% and this was lower than the 47.5% from Bil-
bis et al15 in Sokoto, North West Nigeria, and 72% by 
Muller et al 16 in rural Burkina Faso, but higher than 
11% by Takyi et al17 in Ghana. While the present study 
investigated children between 18 and 192 months, Bilbis 
et al,15 studied only children less than 60 months. Chil-
dren less than 60 months have lower zinc levels than 
older children because of the higher demand for growth 
and reduced intake from diet.2 The higher prevalence in 
the study by Muller et al can be attributed to the fact that 
a sub-sample of a population rather than the whole 
population was used. The method of recruitment of this 
sub sample was not stated and it may have caused some 
bias in favour of zinc deficiency. Another reason fr the 
higher prevalence in the study by Muller et al, was that 
113 
the children investigated were said to have consumed 
mainly cereals with little protein in their diet and this 
can account for the reduction of zinc in that population 
as zinc is known to be low in cereals.2,3  Takyi et al17 
had a much lower prevalence possibly because they us d 
hair zinc levels for their study which reflects chronic 
zinc nutrition rather than acute as serum zinc levels  
determines.     
 
The mean serum zinc level in subjects was significantly 
lower than that found in controls. This was comparable 
to other studies in Nigeria,15 and Kenya.16 Though the 
other studies investigated adults, the difference between 
subjects and controls may be attributed to the fact that 
HIV, being a chronic infection, predisposes infected 
individuals to under-nutrition and other opportunistic 
infections, putting excessive stress on the immune sys-
tem and lowering the zinc levels in serum. The low se-
rum zinc levels in some of the controls may be attribu -
able to their ill-health poor appetite, reduced dietary zinc 
intake and the high zinc turnover rate during illness, and 
since there are no readily available stores in the body, 
that which is available for assay will be low. 
 
Mean serum zinc level in subjects was noticed to be 
lower, though not significantly, in the younger age 
groups than in the older age groups. Bilbis et al, 12 in 
Northern Nigeria also noted similar findings in their 
study. Within the same age group, mean serum zinc lev-
els were lower in subjects than in the controls. This may 
be a reflection of the HIV disease burden on the sub-
jects. Lower serum zinc levels in younger children may 
be a consequence of higher turnover of zinc as it i 
needed for growth, metabolism and to fight infection, 
thereby reducing that which is available in serum for 
analysis.2 Again, younger children who are being 
weaned off milk onto other diets are usually given c re-
als that are poor sources of zinc and these contain high 
levels of phytate that reduce the absorption of zinc from 
the diet.2   
 
Advanced HIV disease stage was associated with low 
mean serum zinc levels. This significant difference was 
also seen in Uganda, South Africa,11 and Kenya,16 even 
though adult population was used in the Kenyan study.16 
Advanced HIV disease stage is more likely to be associ-
ated with recurrent and chronic infections thus reducing 
intake and increasing zinc turnover. There were also 
significantly lower serum zinc levels in subjects who 
had evidence of immune suppression than those who did 
not have evidence of immune suppression. This was also 
reported by Eley et al in South Africa.11 It is worth not-
ing here, that immune categorization is better made with 
CD4% and not absolute count in children,10 as the total 
white blood cell count is relatively low in children and 
following HAART administration, CD4+ counts recover 
slowly and may eventually reach optimal levels. 
 
 
CD4+ count and percentage were significantly lower in 
subjects than controls. The low CD4+ count and percent-
age in HIV is a well known phenomenon, as these cells 
are very susceptible to the HIV and they get depletd 
fast in the course of the disease.1, 2, This finding of re-
duced CD4+ count with advanced disease was similar to 
reports from other parts of Nigeria and other developing 
countries.6,8,13 Zinc is required for the enzymes (protease 
and integrase) activities in HIV and as the virus prolifer-
ates and disease progresses, the zinc levels in serum 
decrease. The proliferation also causes release of oxygen 
free radicals and superoxide dismutase is used to mop 
up these free radicals to prevent their accumulation o 
toxic levels. 
 
Another significant finding in the present study was that 
the lower the socioeconomic status of the guardians, the 
lower the serum zinc levels of study groups though there 
were fluctuations in some classes, and this was seen in 
other studies.4, 17 Subjects in the same socioeconomic 
class with controls had lower mean serum zinc levels. 
The association has not been looked at in other studies, 
and though there were more subjects in lower socioeco-
nomic classes, the finding shows that there is reduc  
serum zinc levels in children of low socioeconomic 
class.17 Children of lower socioeconomic status have 
low access to food rich in zinc, and consume diets rich 
in phytate, thereby decreasing their serum zinc levels. 
These children are also prone to recurrent infections, and 
as their immune system attempts to fight these infec-
tions, there is reduction in serum zinc levels.2,3,19  Those 
parents in lower socioeconomic classes whose children 
presented in advanced disease stages may have poor 
health seeking behaviour and thus not present untilthe 
illness was advanced. Poverty may also be a contribut-




Conclusion and Recommendation 
 
Our study showed a high prevalence of zinc deficiency 
in HIV infected children (60%), and also in controls 
(40%). Most of the zinc deficient children were in low 
socioeconomic class, ages less than 60 months and in 
advanced HIV disease stage. The mean serum zinc lev-
els were also low in HIV sero-positive. It is therefor  
our recommendation that all HIV infected children 
should be supplemented with zinc immediately after 
being diagnosed to reduce the co-morbidities associated 
with the infection and improves their immunity. 
 
Limitation of the study 
 
The trend or change of serum zinc levels could not be 
ascertained as this was a case- control study. A longitu-
dinal study might have assessed this change over tim .
Dietary intakes of nutrients were not assessed, as this is 
one of the main ways of assessing zinc levels. The cost 
of the study was high. 
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